Unknown

Dataset Information

0

Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients.


ABSTRACT: Anti-cancer drugs often increase reactive oxygen species (ROS) and cause DNA damage. Here, we highlight a new cross talk between chronic oxidative stress and the histone variant H2AX, a key player in DNA repair. We observe that persistent accumulation of ROS, due to a deficient JunD-/Nrf2-antioxidant response, reduces H2AX protein levels. This effect is mediated by an enhanced interaction of H2AX with the E3 ubiquitin ligase RNF168, which is associated with H2AX poly-ubiquitination and promotes its degradation by the proteasome. ROS-mediated H2AX decrease plays a crucial role in chemosensitivity. Indeed, cycles of chemotherapy that sustainably increase ROS reduce H2AX protein levels in Triple-Negative breast cancer (TNBC) patients. H2AX decrease by such treatment is associated with an impaired NRF2-antioxidant response and is indicative of the therapeutic efficiency and survival of TNBC patients. Thus, our data describe a novel ROS-mediated regulation of H2AX turnover, which provides new insights into genetic instability and treatment efficacy in TNBC patients.

SUBMITTER: Gruosso T 

PROVIDER: S-EPMC5123617 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients.

Gruosso Tina T   Mieulet Virginie V   Cardon Melissa M   Bourachot Brigitte B   Kieffer Yann Y   Devun Flavien F   Dubois Thierry T   Dutreix Marie M   Vincent-Salomon Anne A   Miller Kyle Malcolm KM   Mechta-Grigoriou Fatima F  

EMBO molecular medicine 20160502 5


Anti-cancer drugs often increase reactive oxygen species (ROS) and cause DNA damage. Here, we highlight a new cross talk between chronic oxidative stress and the histone variant H2AX, a key player in DNA repair. We observe that persistent accumulation of ROS, due to a deficient JunD-/Nrf2-antioxidant response, reduces H2AX protein levels. This effect is mediated by an enhanced interaction of H2AX with the E3 ubiquitin ligase RNF168, which is associated with H2AX poly-ubiquitination and promotes  ...[more]

Similar Datasets

| S-EPMC7522638 | biostudies-literature
| S-EPMC5524969 | biostudies-literature
| S-EPMC10987140 | biostudies-literature
| S-EPMC7247303 | biostudies-literature
| S-EPMC7226188 | biostudies-literature
2018-03-09 | GSE102548 | GEO
| S-EPMC1747208 | biostudies-literature
| S-EPMC6943739 | biostudies-literature
| S-EPMC7821730 | biostudies-literature